✦ LIBER ✦

Genotypic analysis of lamivudine (LAM)-resistant HBV and their sensitivities to adefovir (ADV) in vitro and in liver transplanted patients

✍ Scribed by S. Xiong; C. Westland; H. Yang; P. Lamy; H. Namini; A. Hung; C. Gibbs; M. Miller; J. Fry; C. Brosgart

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adefovir dipivoxil (ADV) for the treatme

✍ E. Schiff; P. Neuhaus; H. Tillman; D. Samuel; N. Terrault; F. Durand; S. Xiong; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 157 KB

[57] 3 YEARS OF ADEFOVIR AND LAMIVUDINE

✍ P. Lampertico; M. Vigano; E. Manenti; M. Tavarone; G. Lunghi; E. Del Ninno; M. C 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Safety and efficacy of long-term adefovi

✍ Yves Benhamou; M. Bochet; V. Thibault; V. Calvez; M.H. Fievet; Mark Sullivan; Ca 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 115 KB

3 years of adefovir and lamivudine combi

✍ P. Lampertico; M. Viganò; E. Manenti; M. Iavarone; G. Lunghi; E. Del Ninno; M. C 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 59 KB

7 Adefovir dipivoxil (ADV) provides sign

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 117 KB

438 Continued safety and efficacy of add

✍ R. Perrillo; B. Willems; N. Leung; C. Trepo; H.W.L. Hann; G. Lau; W.M. Lee; E. S 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 61 KB